Shannon Robinson

Shannon Robinson supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that sustain the agency’s regulatory science infrastructure. Responsible for managing complex acquisitions in support of laboratory operations and scientific research, Robinson oversees contracts for high-precision analytical instrumentation, specialized consulting services, and technical maintenance solutions essential to FDA’s public health mission. Their work ensures the agency maintains cutting-edge capabilities in drug safety evaluation, medical device testing, and biological product oversight through timely and compliant sourcing practices. Robinson maintains consistent working relationships with key contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for specialized vendors with deep expertise in preclinical research, toxicology, and pharmaceutical development. These partnerships are characterized by long-term, performance-based engagements that prioritize technical rigor, regulatory compliance, and scientific accuracy, often supporting multi-year operational needs across FDA’s laboratory and field sites. While the majority of acquisitions are conducted under open competition, Robinson demonstrates a deliberate commitment to small business participation, with approximately 25% of contracts structured as total small business set-asides under FAR 19.5. This reflects a strategic alignment with federal socioeconomic goals, fostering innovation and capacity-building among qualified small businesses without compromising the technical demands of FDA’s regulatory mission. The procurement portfolio is heavily concentrated in NAICS 334516 (analytical laboratory instrument manufacturing), 811210 (electronic and precision equipment repair), 423850 (service establishment equipment wholesaling), and 541690 (scientific and technical consulting services). These categories underscore expertise in procuring advanced instrumentation, maintenance support for mass spectrometers and chromatography systems, and specialized scientific advisory services critical to FDA’s core regulatory functions.